Drug Repurposing Prediction for Immune-Mediated Cutaneous Diseases using a Word-Embedding–Based Machine Learning Approach
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Immune-mediated diseases affect >20% of the population and many autoimmune diseases affect the skin. Drug repurposing (aka repositioning) is a cost-effective approach for revealing drugs that can be used to treat diseases for which they are currently not prescribed. We implemented an efficient bioinformatics approach using “word embedding” to summarize drug information from >20 million articles, and applied machine learning to model the drug-disease relationship. We trained our drug repurposing approach separately on 9 cutaneous diseases (including psoriasis, atopic dermatitis and alopecia areata), as well as 8 other immune-mediated diseases, and obtained a mean AUROC of 0.93 in cross-validation. Focusing in particular on psoriasis, a chronic inflammatory condition of skin that affects >100 million people worldwide, we were able to confirm drugs that are known to be effective for psoriasis, and identify potential candidates used to treat other diseases. Furthermore, the targets of drug candidates predicted by our approach were significantly enriched among genes differentially expressed in psoriatic lesional skin from a large-scale RNA-seq cohort. While our algorithm cannot be used to determine clinical efficacy, our work provides an approach for suggesting drugs for repurposing to immune-mediated cutaneous diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
WITHDRAWN—a resource for withdrawn and discontinued drugs
Siramshetty, V. B., Nickel, J., Omieczynski, C., Gohlke, B.-O., Drwal, M. N., & Preissner, R. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1192 · Cited by 286
RetractedEnriching Word Vectors with Subword Information
Bojanowski, P., Grave, E., Joulin, A., & Mikolov, T. (2017) · Transactions of the Association for Computational Linguistics · doi:10.1162/tacl_a_00051 · Cited by 9,645
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
Innovation in the pharmaceutical industry: New estimates of R&D costs
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.01.012 · Cited by 3,359 · cited 1×
“Developing a new drug typically takes an average 10-15 years, and costs >$2 billion (DiMasi et al., 2016).”
BackgroundGenetics of rheumatoid arthritis contributes to biology and drug discovery
the RACI consortium, Okada, Y., the GARNET consortium, Wu, D., Trynka, G., Raj, T., Terao, C., Ikari, K., Kochi, Y., Ohmura, K., et al. (2014) · Nature · doi:10.1038/nature12873 · Cited by 2,310 · cited 1×
“, 2012), eQTL analysis (Okada et al., 2014), GWAS-imputed transcriptome (Pritchard et al.”
MethodDeep learning with word embeddings improves biomedical named entity recognition
Habibi, M., Weber, L., Neves, M., Wiegandt, D. L., & Leser, U. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx228 · Cited by 542 · cited 1×
“Word embeddings have previously been used for named entity recognition (Habibi et al., 2017) and identifying adverse drug reactions from social media (Nikfarjam et al.”
MethodLiterature Based Discovery: Models, methods, and trends
Henry, S., & McInnes, B. T. (2017) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2017.08.011 · Cited by 121
Cited by
Machine Learning in Dermatology: Current Applications, Opportunities, and Limitations
Chan, S., Reddy, V., Myers, B., Thibodeaux, Q., Brownstone, N., & Liao, W. (2020) · Dermatology and Therapy · doi:10.1007/s13555-020-00372-0 · Cited by 267
Exploration of databases and methods supporting drug repurposing: a comprehensive survey
Tanoli, Z., Seemab, U., Scherer, A., Wennerberg, K., Tang, J., & Vähä-Koskela, M. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa003 · Cited by 131
Machine learning applications in the evaluation and management of psoriasis: a systematic review
Yu, K., Syed, M. N., Bernardis, E., & Gelfand, J. M. (2020) · Journal of Psoriasis and Psoriatic Arthritis · doi:10.1177/2475530320950267 · Cited by 65
Current State and Prospects of Artificial Intelligence in Allergy
van Breugel, M., Fehrmann, R. S. N., Bügel, M., Rezwan, F. I., Holloway, J. W., Nawijn, M. C., Fontanella, S., Custovic, A., & Koppelman, G. H. (2023) · Allergy · doi:10.1111/all.15849 · Cited by 43
Machine learning for precision dermatology: Advances, opportunities, and outlook
Lee, E. Y., Maloney, N. J., Cheng, K., & Bach, D. Q. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.06.1019 · Cited by 14
Metadata
- Authors
- Patrick, M. T., Raja, K., Miller, K., Sotzen, J., Gudjonsson, J. E., Elder, J. T., & Tsoi, L. C.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 139
- Issue
- 3
- Pages
- 683-691
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2896479849
- Cited by
- 73
- References
- 7
- FWCI
- 5.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drug Repurposing Prediction for Immune-Mediated Cutaneous Diseases using a Word-Embedding–Based Machine Learning Approach. https://app.cochat.ai/papers/10.1016/j.jid.2018.09.018
- The paper
- Patrick, M. T., Raja, K., Miller, K., Sotzen, J., Gudjonsson, J. E., Elder, J. T., & Tsoi, L. C. (2019). Drug Repurposing Prediction for Immune-Mediated Cutaneous Diseases using a Word-Embedding–Based Machine Learning Approach. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2018.09.018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.